{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:51:07Z","timestamp":1781880667602,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Department, Hubei Provincial People\u2019s Government","award":["2020CFB421"],"award-info":[{"award-number":["2020CFB421"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070631"],"award-info":[{"award-number":["82070631"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Differential diagnosis between tuberculous peritonitis and peritoneal carcinomatosis remains challenging in clinical practice; thus, in-patients diagnosed with tuberculous peritonitis or peritoneal carcinomatosis were retrospectively enrolled, and diagnostic values of ascitic tumor markers and adenosine deaminase were determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Consecutive patients diagnosed with tuberculous peritonitis or peritoneal carcinomatosis were retrospectively enrolled. The pertinent data of 169 patients enrolled were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A panel of ascitic tumor makers (CEA, CA15-3, CA19-9) had high specificity (96.83%) and accuracy (94.67%) in the differentiation of peritoneal carcinomatosis from tuberculous peritonitis; and ascitic ADA was a good discriminator between these patients, with an accuracy of 91.72%. Combined use of ascitic tumor makers and ADA (ascitic ADA\u2009&lt;\u200922.5\u00a0IU\/L or ascitic CEA\u2009&gt;\u20093.65\u00a0ng\/mL or CA15-3\u2009&gt;\u200942.70 U\/mL or CA19-9\u2009&gt;\u200925.10 U\/mL) performed high sensitivity (99.06%) and accuracy (94.08%) for the diagnosis of peritoneal carcinomatosis. In addition, combined ascitic ADA and tumor marker (positive ascitic tumor makers and ADA\u2009&lt;\u200922.50\u00a0IU\/L) had 100% of the specificity in diagnosing peritoneal carcinomatosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Combined use of ascitic tumor markers and adenosine deaminase showed excellent efficiency in the differential diagnosis between tuberculous peritonitis and peritoneal carcinomatosis, thus these two simple and cost\u2010effective parameters should be determined when tuberculous peritonitis or peritoneal carcinomatosis was suspected in clinic practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02480-x","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T14:02:27Z","timestamp":1663423347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Utility of ascitic tumor markers and adenosine deaminase for differential diagnosis of tuberculous peritonitis and peritoneal carcinomatosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Li","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanglong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"2480_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1365-2036.2005.02645.x","volume":"22","author":"FM Sanai","year":"2005","unstructured":"Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis\u2013presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther. 2005;22:685\u2013700.","journal-title":"Aliment Pharmacol Ther"},{"key":"2480_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/apt.15042","volume":"49","author":"L Du","year":"2019","unstructured":"Du L, Zhu S, Lu Z, Xu T, Bai T, Xu D, Wei X, et al. Ascitic cholesterol is superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites and the diagnosis of mixed ascites. Aliment Pharmacol Ther. 2019;49:91\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"2480_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-021-02077-6","volume":"27","author":"K Matsusaki","year":"2022","unstructured":"Matsusaki K, Aridome K, Emoto S, Kajiyama H, Takagaki N, Takahashi T, Tsubamoto H, et al. Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021). Int J Clin Oncol. 2022;27:1\u20136.","journal-title":"Int J Clin Oncol"},{"key":"2480_CR4","doi-asserted-by":"publisher","first-page":"e245311","DOI":"10.1136\/bcr-2021-245311","volume":"14","author":"H Kushima","year":"2021","unstructured":"Kushima H, Sakamoto R, Kinoshita Y, Ishii H. Tuberculous peritonitis. BMJ Case Rep. 2021;14:e245311.","journal-title":"BMJ Case Rep"},{"key":"2480_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jgh.14768","volume":"35","author":"S Zhu","year":"2020","unstructured":"Zhu S, Du L, Xu D, Lu Z, Xu T, Li J, Xu K, et al. Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites. J Gastroenterol Hepatol. 2020;35:271\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"2480_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/apt.15105","volume":"49","author":"L Du","year":"2019","unstructured":"Du L, Zhu S, Hou X, Song Y. Editorial: ascitic cholesterol\u2014is it superior to serum-ascites albumin gradient? Authors\u2019 reply. Aliment Pharmacol Ther. 2019;49:815\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"2480_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.radcr.2019.09.026","volume":"14","author":"B Aslan","year":"2019","unstructured":"Aslan B, Tuney D, Almoabid ZAN, Ercetin Y, Seven IE. Tuberculous peritonitis mimicking carcinomatosis peritonei: CT findings and histopathologic correlation. Radiol Case Rep. 2019;14:1491\u20134.","journal-title":"Radiol Case Rep"},{"key":"2480_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000072919","volume":"56","author":"A Protopapas","year":"2003","unstructured":"Protopapas A, Milingos S, Diakomanolis E, Elsheikh A, Protogerou A, Mavrommatis K, Michalas S. Miliary tuberculous peritonitis mimicking advanced ovarian cancer. Gynecol Obstet Invest. 2003;56:89\u201392.","journal-title":"Gynecol Obstet Invest"},{"key":"2480_CR9","first-page":"113","volume":"22","author":"S Imtiaz","year":"2012","unstructured":"Imtiaz S, Siddiqui N, Ahmad M, Jahan A. Pelvic-peritoneal tuberculosis mimicking ovarian cancer. J Coll Physicians Surg Pak. 2012;22:113\u20135.","journal-title":"J Coll Physicians Surg Pak"},{"key":"2480_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/lap.2018.0274","volume":"29","author":"B Abayli","year":"2019","unstructured":"Abayli B, Gencdal G. A single-center experience: the diagnostic role of peritoneoscopy in patients with exudative ascites. J Laparoendosc Adv Surg Tech A. 2019;29:51\u20134.","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"2480_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3329\/bmrcb.v40i3.25228","volume":"40","author":"N Ali","year":"2014","unstructured":"Ali N, Nath NC, Parvin R, Rahman A, Bhuiyan TM, Rahman M, Mohsin MN. Role of ascitic fluid adenosine deaminase (ADA) and serum CA-125 in the diagnosis of tuberculous peritonitis. Bangladesh Med Res Counc Bull. 2014;40:89\u201391.","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"2480_CR12","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.3748\/wjg.v18.i22.2837","volume":"18","author":"SJ Kang","year":"2012","unstructured":"Kang SJ, Kim JW, Baek JH, Kim SH, Kim BG, Lee KL, Jeong JB, et al. Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis. World J Gastroenterol. 2012;18:2837\u201343.","journal-title":"World J Gastroenterol"},{"key":"2480_CR13","doi-asserted-by":"publisher","first-page":"5792937","DOI":"10.1155\/2020\/5792937","volume":"2020","author":"A Kumabe","year":"2020","unstructured":"Kumabe A, Hatakeyama S, Kanda N, Yamamoto Y, Matsumura M. Utility of ascitic fluid adenosine deaminase levels in the diagnosis of tuberculous peritonitis in general medical practice. Can J Infect Dis Med Microbiol. 2020;2020:5792937.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2480_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/hep.510240617","volume":"24","author":"DJ Hillebrand","year":"1996","unstructured":"Hillebrand DJ, Runyon BA, Yasmineh WG, Rynders GP. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology. 1996;24:1408\u201312.","journal-title":"Hepatology"},{"key":"2480_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1665-2681(19)30865-8","volume":"13","author":"F Liu","year":"2014","unstructured":"Liu F, Kong X, Dou Q, Ye J, Xu D, Shang H, Xu K, et al. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Ann Hepatol. 2014;13:357\u201363.","journal-title":"Ann Hepatol"},{"key":"2480_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/ggi.12412","volume":"15","author":"DK Das","year":"2015","unstructured":"Das DK. Age and sex distribution in malignant and tuberculous serous effusions: a study of 127 patients and review of the literature. Geriatr Gerontol Int. 2015;15:1143\u201350.","journal-title":"Geriatr Gerontol Int"},{"key":"2480_CR17","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.2147\/CMAR.S271596","volume":"12","author":"L Deng","year":"2020","unstructured":"Deng L, Guo S, Li H, You X, Song Y, Su H. CA125, CEA, CA19-9, and heteroploid cells in ascites fluid may help diagnose peritoneal carcinomatosis in patients with gastrointestinal and ovarian malignancies. Cancer Manag Res. 2020;12:10479\u201389.","journal-title":"Cancer Manag Res"},{"key":"2480_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.clinbiochem.2013.02.010","volume":"46","author":"EJ Kaleta","year":"2013","unstructured":"Kaleta EJ, Tolan NV, Ness KA, O\u2019Kane D, Algeciras-Schimnich A. CEA, AFP and CA 19\u20139 analysis in peritoneal fluid to differentiate causes of ascites formation. Clin Biochem. 2013;46:814\u20138.","journal-title":"Clin Biochem"},{"key":"2480_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7314\/APJCP.2015.16.2.719","volume":"16","author":"FL Zhu","year":"2015","unstructured":"Zhu FL, Ling AS, Wei Q, Ma J, Lu G. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites. Asian Pac J Cancer Prev. 2015;16:719\u201322.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2480_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1590-8658(00)80841-5","volume":"32","author":"MR Mas","year":"2000","unstructured":"Mas MR, Comert B, Saglamkaya U, Yamanel L, Kuzhan O, Ateskan U, Kocabalkan F. CA-125; a new marker for diagnosis and follow-up of patients with tuberculous peritonitis. Dig Liver Dis. 2000;32:595\u20137.","journal-title":"Dig Liver Dis"},{"key":"2480_CR21","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/ccr3.3040","volume":"8","author":"G Motoa","year":"2020","unstructured":"Motoa G, Alvarez S. Tuberculous peritonitis masquerading as carcinomatosis. Clin Case Rep. 2020;8:2078\u20139.","journal-title":"Clin Case Rep"},{"key":"2480_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1590\/s0004-2803.202202000-37","volume":"59","author":"T Jain","year":"2022","unstructured":"Jain T, Ram S, Kumar H, Saroch A, Sharma V, Singh H. Ascitic and Serum Levels of Tumor Biomarkers (Ca 72\u20134, Ca 19\u20139, Cea and Ca 125) in Discrimination of Cause of Ascites: A Prospective Study. Arq Gastroenterol. 2022;59:198\u2013203.","journal-title":"Arq Gastroenterol"},{"key":"2480_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00004836-200609000-00009","volume":"40","author":"A Riquelme","year":"2006","unstructured":"Riquelme A, Calvo M, Salech F, Valderrama S, Pattillo A, Arellano M, Arrese M, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis. J Clin Gastroenterol. 2006;40:705\u201310.","journal-title":"J Clin Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02480-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T14:02:36Z","timestamp":1663423356000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02480-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02480-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"20 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki, and the protocol was approved by Ethics Committee of Tongji Medical School, Huazhong University of Science and Technology, which waived the need for informed consent for the present study because of its retrospective nature. And all methods in this study were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}